Regional Overview Eurasia
Regional Overview Eurasia AVAILABILITY OF NEEDLE AND SYRINGE EXCHANGE PROGRAMMES AND OPIOID SUBSTITUTION THERAPY Both NSP and OST available OST only NSP only Neither available Not Known 33 HARM REDUCTION IN EURASIA Adult HIV Adult HCV Harm reduction response Country/territory with prevalence People who prevalence reported injecting amongst inject drugs1 amongst people drug usea people who HIV and HCV programmes targeted who inject drugs3 NSP OST inject drugs2 towards people who inject drugs* Albania 10,0004 nk 26– 65%4 ¸¸ Armenia 2,0005 6.78%6 nk ¸ x Azerbaijan 80,00020 19–24%7 57%17 ¸¸ Belarus 49,8968 16.7%9 39%9 ¸¸ Bosnia and Herzegovina 11,458 nk 30–35%10 ¸¸ Bulgaria 20,000–30,000 †,11 3.43%12 nk ¸¸ Croatia 20,942 0.5–1.93% 58.3–68.6% ¸¸ Czech Republic 27,00013 0–2.7%14 21–59% ¸¸ Estonia 13,80015 54.3–89.9% ‡ circa 90% ¸¸ Georgia 80,00016 0.4%17 64.6%17 ¸¸ Hungary 15,00018 <1.0%14 14–24%19 ¸¸ Kazakhstan 186,00020 3.9%21 65.7%21 ¸ x Kosovo nk 022 13–27%22 xx While there are some targeted HIV Kyrgyzstan 44,00023 3–9%33 28–43%33 ¸¸programmes reaching people who inject drugs in the region, coverage remains very Latvia 18,725 22%14 nk ¸¸ low Lithuania 8,500 2.9%14 79–95.9% ¸¸HCV services in the region are minimal Former Yugoslav Republic nk 24 25 of Macedonia <1% 85.6% ¸¸ Moldova 34,000–52,00026 21%27 nk ¸¸ Montenegro 400–50028 nk nk ¸¸ Poland 96,514 8.9–16%14 55–68%38 ¸¸ Romania 13,694–34,31829 0–0.81% 44–80%38 ¸¸ Russia 2,000,00030 12–30%30 90%31 ¸ x Serbia nk nk nk ¸¸ Slovakia 13,497 <1%14 circa 45%38 ¸¸ Slovenia 5,00032 <1%19 40%38 ¸¸ Tajikistan 15,00033 23.5%34 43.4%25 ¸ x Turkmenistan 11,148 nk nk x nk Ukraine 325,000–435,00036 41.8%37 70–90%38 ¸¸ Uzbekistan 80,00033 15.33%33 5%33 ¸¸ nk = not known * These services include, among others, voluntary HIV testing and counselling; HIV prevention, treatment and care; hepatitis C testing and treatment; STI prevention and treatment; information, education and communication.
[Show full text]